Solara Active Pharma Sciences Limited
NSE:SOLARA.NS
759.55 (INR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 12,889.2 | 14,438.1 | 12,305.5 | 15,757.3 | 12,676.4 | 13,220.83 | 5,209.73 | 9,412.78 |
| Cost of Revenue
| 8,050.2 | 7,888.2 | 6,977.9 | 7,695.8 | 6,407.3 | 7,467.73 | 4,473.46 | 5,028.6 |
| Gross Profit
| 4,839 | 6,549.9 | 5,327.6 | 8,061.5 | 6,269.1 | 5,753.1 | 736.27 | 4,384.18 |
| Gross Profit Ratio
| 0.375 | 0.454 | 0.433 | 0.512 | 0.495 | 0.435 | 0.141 | 0.466 |
| Reseach & Development Expenses
| 420 | 461.6 | 656.2 | 643.5 | 585.7 | 440.5 | 18.18 | 0 |
| General & Administrative Expenses
| 0 | 2,299.2 | 310.3 | 328.5 | 283.4 | 176.4 | 412.9 | 0.204 |
| Selling & Marketing Expenses
| 0 | 8.6 | 53.9 | 76.2 | 55.1 | 63.09 | 7.48 | -0.187 |
| SG&A
| 3,351.6 | 2,307.8 | 364.2 | 404.7 | 338.5 | 239.49 | 420.38 | 0.017 |
| Other Expenses
| 53.7 | 225.5 | 76.3 | 84.6 | 107.9 | 74.67 | -7.87 | 116.13 |
| Operating Expenses
| 6,824.1 | 6,322.9 | 5,500.3 | 5,257.3 | 4,570.4 | 4,243.72 | 446.43 | 3,799.76 |
| Operating Income
| -1,931.4 | 275.9 | -259.9 | 2,846 | 1,731.8 | 1,509.38 | 289.84 | 584.42 |
| Operating Income Ratio
| -0.15 | 0.019 | -0.021 | 0.181 | 0.137 | 0.114 | 0.056 | 0.062 |
| Total Other Income Expenses Net
| -2,952.8 | -724.1 | -651.1 | -631 | -582.7 | -832.45 | -231.57 | -199.9 |
| Income Before Tax
| -4,884.2 | -448.1 | -911 | 2,215 | 1,149.1 | 676.93 | 58.27 | 384.52 |
| Income Before Tax Ratio
| -0.379 | -0.031 | -0.074 | 0.141 | 0.091 | 0.051 | 0.011 | 0.041 |
| Income Tax Expense
| 785.4 | -225.7 | -328.1 | 1.5 | 3.9 | 5.9 | -1.4 | 84.37 |
| Net Income
| -5,673.9 | -221.7 | -581.5 | 2,214 | 1,146.1 | 595.27 | 3.77 | 301.64 |
| Net Income Ratio
| -0.44 | -0.015 | -0.047 | 0.141 | 0.09 | 0.045 | 0.001 | 0.032 |
| EPS
| -145.27 | -6.16 | -16.18 | 69 | 44.29 | 24.11 | 0.15 | 26.94 |
| EPS Diluted
| -145.27 | -6.16 | -16.18 | 64.53 | 42.82 | 24.07 | 0.15 | 26.94 |
| EBITDA
| -898.1 | 1,564.6 | 1,046.1 | 4,081.3 | 2,704.6 | 2,245.73 | 629.67 | 1,251.67 |
| EBITDA Ratio
| -0.07 | 0.108 | 0.085 | 0.259 | 0.213 | 0.17 | 0.121 | 0.133 |